Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154 Primary Care Perspectives: Podcast For Pediatricians podcast

Artwork

Health and Well-Being Primary Care Pediatrics Science Medicine Childrens Hospital Of Philadelphia

Innhold levert av Children's Hospital of Philadelphia. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Children's Hospital of Philadelphia eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Primary Care Perspectives: Podcast for Pediatricians « »
Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

8M ago 20:20

Del

MP3•Episoder hjem

Innhold levert av Children's Hospital of Philadelphia. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Children's Hospital of Philadelphia eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, details the science behind the monoclonal antibody, nirsevimab (Beyfortus) and its importance, safety and efficacy, side effects, administration and proven benefits, such as a decrease in morbidity, as shown by clinical trials; and more.

… continue reading

159 episoder

#Health and Well-Being #Primary Care #Pediatrics #Science #Medicine #Childrens Hospital Of Philadelphia

Artwork

Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

Primary Care Perspectives: Podcast for Pediatricians

92 subscribers

published 8M ago

Del

MP3•Episoder hjem

Innhold levert av Children's Hospital of Philadelphia. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Children's Hospital of Philadelphia eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, details the science behind the monoclonal antibody, nirsevimab (Beyfortus) and its importance, safety and efficacy, side effects, administration and proven benefits, such as a decrease in morbidity, as shown by clinical trials; and more.

… continue reading

159 episoder

#Health and Well-Being #Primary Care #Pediatrics #Science #Medicine #Childrens Hospital Of Philadelphia

Alle episoder

×

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

Lytt til 500+ tema